|
TTC30B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63913327355658E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65067959301268E-12 |
| Normal-vs-Stage2 |
2.56899945760836E-10 |
| Normal-vs-Stage3 |
1.62714286489063E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.923500E-02 |
| Stage1-vs-Stage3 |
2.195800E-01 |
| Stage1-vs-Stage4 |
8.30890000000917E-05 |
| Stage2-vs-Stage3 |
7.319600E-03 |
| Stage2-vs-Stage4 |
6.33709999999787E-05 |
| Stage3-vs-Stage4 |
1.740000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63014046705712E-12 |
| Normal-vs-AfricanAmerican |
5.83849968371908E-10 |
| Normal-vs-Asian |
5.55111512312578E-15 |
| Caucasian-vs-AfricanAmerican |
3.256200E-01 |
| Caucasian-vs-Asian |
8.231600E-01 |
| AfricanAmerican-vs-Asian |
3.437800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65267799445701E-12 |
| Normal-vs-Female |
1.24344978758018E-14 |
| Male-vs-Female |
7.345200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63025148935958E-12 |
| Normal-vs-Age(41-60Yrs) |
2.65343302885412E-14 |
| Normal-vs-Age(61-80Yrs) |
1.65423230669148E-12 |
| Normal-vs-Age(81-100Yrs) |
2.421900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.058200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.351600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.683800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.222600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.834400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.544000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.94829999999868E-06 |
| Classical-VS-Follicular |
7.171000E-04 |
| Classical-VS-Other |
8.705600E-01 |
| Classical-VS-Normal |
1.64734892393881E-12 |
| Tall-VS-Follicular |
1.4304000206522E-09 |
| Tall-VS-Other |
3.552800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
2.331200E-01 |
| Follicular-VS-Normal |
1.98499994219503E-10 |
| Other-VS-Normal |
2.998500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80300219199125E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.94170000000771E-06 |
|
|
